# FDA OKs First Drug for Primary Membranous Nephropathy

Source: [MedPageToday.com - medical news for physicians](https://www.medpagetoday.com/nephrology/generalnephrology/123892) · 2026-11-16 · Medicine
Page: https://themorning.science/story/fda-oks-first-drug-for-primary-membranous-nephropathy-16c28831782d6710
Kind: other · Impact: medium

## In brief

- The FDA expanded the label for the B-cell depleter obinutuzumab (Gazyva) to include treatment of primary membranous nephropathy.
- MedPage Today describes this as the first drug approved for primary membranous nephropathy.
- The FDA announced the new indication on a Friday; the source snippet does not give the exact date or the full conditions of use.

## Why it matters

It adds an approved drug option for a kidney disease, which matters to science readers following how laboratory and clinical research becomes treatment.

## Coverage

- [FDA OKs First Drug for Primary Membranous Nephropathy](https://www.medpagetoday.com/nephrology/generalnephrology/123892) — MedPageToday.com - medical news for physicians, 2026-11-16

Tags: fda, nephrology, drug approval, obinutuzumab, membranous nephropathy

---

Brief generated by AI (claude-haiku-5-5) from the reporting listed under Coverage. Headlines belong to their publishers. The Morning Science – https://themorning.science
